Literature DB >> 31333210

Flexible Fiberoptic Bronchoscopy Directed Interventions in Neonatal Intensive Care Unit.

Anil Sachdev1, Ritika Chhawchharia2, Dhiren Gupta2, Neeraj Gupta2.   

Abstract

OBJECTIVE: To describe the utility of flexible fiberoptic bronchoscopy for the diagnosis and management in the neonatal ICU.
METHODS: A retrospective, medical chart review was conducted in neonates who underwent flexible fiberoptic bronchoscopy over a period of 7 years. Besides demographic data and diagnostic findings, the results of medical and/or surgical interventions done by treating neonatologist were recorded.
RESULTS: 88 bronchoscopies were performed in 83 neonates, of which 37 were done through endotracheal tube. Indications included persistent need for mechanical ventilation (32), persistent atelectasis (21), and stridor (27). Most common airway anomalies diagnosed included tracheobronchomalacia (20), laryngomalacia (18), subglottic stenosis (7), choanal atresia (4), laryngeal cleft (4), and tracheoesophageal fistula (4). Surgical interventions were undertaken in 17 cases (9 tracheostomies and 2 cases of slide tracheoplasty).
CONCLUSIONS: Flexible fiberoptic bronchoscopy can be beneficial for the diagnosis and management of neonates with persistent or undiagnosed respiratory problems.

Entities:  

Mesh:

Year:  2019        PMID: 31333210

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  2 in total

1.  A multicenter survey of pediatric flexible bronchoscopy in western China.

Authors:  Jilei Lin; Xingping Tao; Wanmin Xia; Jing Liu; Lin Zhong; Xin Sun; Lu Liu; Lei Li; Rong Jin; Li Cheng; Zhongtao Wang; Zhengxiu Luo; Qubei Li; Enmei Liu; Zhou Fu; Jihong Dai
Journal:  Transl Pediatr       Date:  2021-01

2.  Effect of Sufentanil Combined with Nalmefene Assisted Surface Anesthesia on Transnasal Endotracheal Intubation Guided by Fiberoptic Bronchoscope.

Authors:  Zhanqi Zhao; Junting Zhang; Yuru Zhan; Zhongqun Wang
Journal:  Contrast Media Mol Imaging       Date:  2022-09-09       Impact factor: 3.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.